Femara 2.5 mg Film-Coated Tablets 30's is a letrozole aromatase-inhibitor tablet used for hormone-sensitive breast cancer; fertility specialists may also use it for monitored ovulation induction. Its confirmed composition is Letrozole 2.5 mg per film-coated tablet; pack of 30 tablets.

For breast-cancer treatment, the usual adult dose is one 2.5 mg tablet once daily. Fertility regimens use a short, cycle-timed course selected by the specialist, so the cycle day and number of treatment days must be recorded clearly. Do not use during pregnancy.

Hot flushes, joint or muscle pain, headache, tiredness, dizziness, nausea or reduced bone density with prolonged use may occur. Seek urgent care for severe allergy, chest pain, stroke-like symptoms or severe bone pain. Seek medical or pharmaceutical advice if symptoms are severe, persistent or worsening.